PharmaMar Begins Aplidin Phase III Registration Trial Admyre
Reportedly, the pivotal, international, multicenter Phase III clinical trial, called Admyre, is expected to enroll 300 patients in 60 medical centers across 20 countries (including the US, Europe,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.